Cargando…

A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies

Non-alcoholic steatohepatitis (NASH) is a fatty liver disease characterized by accumulation of fat in hepatocytes with concurrent inflammation and is associated with morbidity, cirrhosis and liver failure. After extraction of a liver core biopsy, tissue sections are stained with hematoxylin and eosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Joshua J., Azizgolshani, Nasim, Andersen, Michael J., Suriawinata, Arief, Liu, Xiaoying, Lisovsky, Mikhail, Ren, Bing, Bobak, Carly A., Christensen, Brock C., Vaickus, Louis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985027/
https://www.ncbi.nlm.nih.gov/pubmed/33299110
http://dx.doi.org/10.1038/s41379-020-00718-1
_version_ 1783668156714188800
author Levy, Joshua J.
Azizgolshani, Nasim
Andersen, Michael J.
Suriawinata, Arief
Liu, Xiaoying
Lisovsky, Mikhail
Ren, Bing
Bobak, Carly A.
Christensen, Brock C.
Vaickus, Louis J.
author_facet Levy, Joshua J.
Azizgolshani, Nasim
Andersen, Michael J.
Suriawinata, Arief
Liu, Xiaoying
Lisovsky, Mikhail
Ren, Bing
Bobak, Carly A.
Christensen, Brock C.
Vaickus, Louis J.
author_sort Levy, Joshua J.
collection PubMed
description Non-alcoholic steatohepatitis (NASH) is a fatty liver disease characterized by accumulation of fat in hepatocytes with concurrent inflammation and is associated with morbidity, cirrhosis and liver failure. After extraction of a liver core biopsy, tissue sections are stained with hematoxylin and eosin (H&E) to grade NASH activity, and stained with trichrome to stage fibrosis. Methods to computationally transform one stain into another on digital whole slide images (WSI) can lessen the need for additional physical staining besides H&E, reducing personnel, equipment, and time costs. Generative adversarial networks (GAN) have shown promise for virtual staining of tissue. We conducted a large-scale validation study of the viability of GANs for H&E to trichrome conversion on WSI (n = 574). Pathologists were largely unable to distinguish real images from virtual/synthetic images given a set of twelve Turing Tests. We report high correlation between staging of real and virtual stains ([Formula: see text] ; 95% CI: 0.84–0.88). Stages assigned to both virtual and real stains correlated similarly with a number of clinical biomarkers and progression to End Stage Liver Disease (Hazard Ratio HR = 2.06, 95% CI: 1.36–3.12, p < 0.001 for real stains; HR = 2.02, 95% CI: 1.40–2.92, p < 0.001 for virtual stains). Our results demonstrate that virtual trichrome technologies may offer a software solution that can be employed in the clinical setting as a diagnostic decision aid.
format Online
Article
Text
id pubmed-7985027
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-79850272021-04-12 A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies Levy, Joshua J. Azizgolshani, Nasim Andersen, Michael J. Suriawinata, Arief Liu, Xiaoying Lisovsky, Mikhail Ren, Bing Bobak, Carly A. Christensen, Brock C. Vaickus, Louis J. Mod Pathol Article Non-alcoholic steatohepatitis (NASH) is a fatty liver disease characterized by accumulation of fat in hepatocytes with concurrent inflammation and is associated with morbidity, cirrhosis and liver failure. After extraction of a liver core biopsy, tissue sections are stained with hematoxylin and eosin (H&E) to grade NASH activity, and stained with trichrome to stage fibrosis. Methods to computationally transform one stain into another on digital whole slide images (WSI) can lessen the need for additional physical staining besides H&E, reducing personnel, equipment, and time costs. Generative adversarial networks (GAN) have shown promise for virtual staining of tissue. We conducted a large-scale validation study of the viability of GANs for H&E to trichrome conversion on WSI (n = 574). Pathologists were largely unable to distinguish real images from virtual/synthetic images given a set of twelve Turing Tests. We report high correlation between staging of real and virtual stains ([Formula: see text] ; 95% CI: 0.84–0.88). Stages assigned to both virtual and real stains correlated similarly with a number of clinical biomarkers and progression to End Stage Liver Disease (Hazard Ratio HR = 2.06, 95% CI: 1.36–3.12, p < 0.001 for real stains; HR = 2.02, 95% CI: 1.40–2.92, p < 0.001 for virtual stains). Our results demonstrate that virtual trichrome technologies may offer a software solution that can be employed in the clinical setting as a diagnostic decision aid. Nature Publishing Group US 2020-12-09 2021 /pmc/articles/PMC7985027/ /pubmed/33299110 http://dx.doi.org/10.1038/s41379-020-00718-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Levy, Joshua J.
Azizgolshani, Nasim
Andersen, Michael J.
Suriawinata, Arief
Liu, Xiaoying
Lisovsky, Mikhail
Ren, Bing
Bobak, Carly A.
Christensen, Brock C.
Vaickus, Louis J.
A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
title A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
title_full A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
title_fullStr A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
title_full_unstemmed A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
title_short A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
title_sort large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985027/
https://www.ncbi.nlm.nih.gov/pubmed/33299110
http://dx.doi.org/10.1038/s41379-020-00718-1
work_keys_str_mv AT levyjoshuaj alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT azizgolshaninasim alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT andersenmichaelj alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT suriawinataarief alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT liuxiaoying alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT lisovskymikhail alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT renbing alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT bobakcarlya alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT christensenbrockc alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT vaickuslouisj alargescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT levyjoshuaj largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT azizgolshaninasim largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT andersenmichaelj largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT suriawinataarief largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT liuxiaoying largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT lisovskymikhail largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT renbing largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT bobakcarlya largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT christensenbrockc largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies
AT vaickuslouisj largescaleinternalvalidationstudyofunsupervisedvirtualtrichromestainingtechnologiesonnonalcoholicsteatohepatitisliverbiopsies